Anti-Aging Peptide Serum for Aging
What You Need to Know Before You Apply
What is the purpose of this trial?
This study tests whether certain medicines and a skin treatment can slow down or partly reverse the body's aging process.
As people age, the activity of their genes changes in predictable ways. Researchers can now measure a person's "biological age" from these gene-activity patterns in skin and blood. This study uses that measurement to see whether treatment can lower a person's biological age compared with their own starting point.
Adults in the study take geroprotective ("age-protecting") agents by mouth or by injection. A separate skin serum containing small anti-aging peptides is applied to certain areas of skin, and those treated areas are compared with untreated areas on the same person.
Skin and blood samples are taken at set times to measure biological age and markers of cell aging before, during, and after treatment. The main goal is to find out whether treatment lowers measured biological age in skin and blood. The study also looks at whether the treatments are safe and well tolerated.
Who Is on the Research Team?
Siamak Tabibzadeh, MD
Principal Investigator
Frontiers in Bioscience Research Institute and Aging
Are You a Good Fit for This Trial?
This trial is for adults interested in testing treatments that may slow or reverse signs of aging. Participants should be generally healthy and willing to use both oral/injected medicines and a skin serum, as well as provide blood and skin samples.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Topical anti-aging peptide serum
Trial Overview
Researchers are studying whether taking anti-aging medicines by mouth or injection, along with applying an anti-aging peptide serum to the skin, can reduce biological age measured from gene activity in blood and skin. Treated areas are compared to untreated ones on each person.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants receive systemic geroprotective agents (metformin, low-dose chloroquine, ivermectin, or a defined nutritional supplement - collagen lysate, thymoquinone/black seed oil, urolithin) alone or in combination, and/or a topical geroprotective formulation. Blood and skin samples are analyzed by molecular means and amount of SASP (IL6/IL8) will be measured in serum compared with each participant's untreated reference sites and baseline.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Frontiers in Bioscience Research Institute and Aging
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.